Rödl R W, Ozaki T, Hoffmann C, Böttner F, Lindner N, Winkelmann W
Department of Orthopaedics, University Hospital, Münster, Germany.
J Bone Joint Surg Br. 2000 Sep;82(7):1006-10. doi: 10.1302/0301-620x.82b7.10644.
We assessed the results of 17 limb-salvage procedures using osteoarticular allografts after wide resection of high-grade malignant bone tumours. All patients received chemotherapy. At the five-year follow-up, three patients had died from metastases. The allografts survived for five years in only seven patients all of whom had good function, ranging from 73% to 90% of normal. The allografts were removed because of fracture in seven patients and infection in one, and in all of these a second limb-salvage procedure was undertaken. With such a low rate of survival of osteoarticular allografts, we believe that their use in the management of high-grade malignant bone tumours should, at best, be considered a temporary solution.
我们评估了17例在广泛切除高级别恶性骨肿瘤后使用骨关节异体移植进行保肢手术的结果。所有患者均接受了化疗。在五年随访时,3例患者死于转移。仅7例患者的异体移植存活了五年,所有这些患者功能良好,功能范围为正常的73%至90%。7例患者因骨折、1例患者因感染而移除了异体移植,所有这些患者均进行了第二次保肢手术。鉴于骨关节异体移植的存活率如此之低,我们认为在高级别恶性骨肿瘤的治疗中使用异体移植充其量应被视为一种临时解决方案。